HPLC is widely used in pharmaceutical analysis for the separation and quantification of active ingredients in complex formulations.

The primary goal of quality control is to guarantee that pharmaceutical products meet predefined standards of safety, quality, and efficacy.

The FDA is the primary regulatory body responsible for ensuring the safety and efficacy of pharmaceutical products in the United States.

Stability studies are conducted to gather data on how a pharmaceutical product changes over time under various conditions, including temperature, humidity, and light exposure.

TLC is a widely used technique for rapidly assessing the purity of pharmaceutical substances by separating and identifying different components in a sample.

Dissolution testing is performed to evaluate the release characteristics of a drug from its dosage form, which is crucial for ensuring its bioavailability and therapeutic efficacy.

GC-MS is a powerful technique for identifying and quantifying impurities in pharmaceutical products due to its high sensitivity and ability to separate and detect a wide range of compounds.

Quality assurance encompasses all activities involved in ensuring that a pharmaceutical product meets predetermined standards of quality and purity, including quality control, validation, and calibration.

21 CFR Part 211 is the regulatory guideline issued by the FDA that provides detailed requirements for GMP in the manufacturing, processing, packing, and holding of pharmaceutical products.

Assay testing is performed to determine the concentration or amount of active ingredients present in a pharmaceutical product, ensuring that it meets the labeled potency.

Laser diffraction is a widely used technique for determining the particle size distribution of pharmaceutical powders by measuring the scattering of laser light by the particles.

Validation is the process of demonstrating that an analytical method consistently produces accurate and reliable results by assessing its performance characteristics, such as accuracy, precision, specificity, and linearity.

21 CFR Part 58 is the regulatory guideline issued by the FDA that provides detailed requirements for GLP in non-clinical safety studies conducted for the development of pharmaceutical products.

Uniformity of dosage units testing is performed to ensure that the individual dosage units within a batch have uniform weight and content of active ingredients, meeting the predetermined specifications.

IR spectroscopy is widely used for the identification of pharmaceutical substances by analyzing the absorption of infrared radiation by functional groups present in the molecule.